Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
23
2024
BETO’s Feedstock-Conversion Interface Consortium Intends to Issue Industrial Partnership Call in September 2024 Bergeson & Campbell, P.C.
Jul
23
2024
FDA Revisits and Updates Guidance on Addressing Misinformation – Ten Years Later Sheppard, Mullin, Richter & Hampton LLP
Jul
23
2024
CMS Sneaks 340B Billing Proposals into Medicare Physician Fee Schedule: What 340B Stakeholders Need to Know McDermott Will & Emery
Jul
23
2024
FSIS to Begin Testing for Allergens in Ready-To-Eat Foods Keller and Heckman LLP
Jul
23
2024
Not a Joy Ride: Navigating DUI Laws for Medical Cannabis Users in Pennsylvania Norris McLaughlin P.A.
Jul
22
2024
EC Seeks Applications for Newly Established Technology Council for Advanced Materials Bergeson & Campbell, P.C.
Jul
22
2024
FTC/FDA Send Letters to THC Edibles Companies Warning of Risks to Children Hunton Andrews Kurth
Jul
19
2024
FDA Pushes to Diversify Clinical Studies, Releases Draft Industry Guidance McDermott Will & Emery
Jul
19
2024
Texas Pharmaceutical Marketer Sentenced for $59 Million Medications Fraud Conspiracy ArentFox Schiff LLP
Jul
19
2024
The Accelerating Kids’ Access to Care Act: Breaking Barriers for Pediatric Patients Across State Lines ArentFox Schiff LLP
Jul
19
2024
Paris Olympics & Paralympics – Part 2: What Could Possibly Go Wrong? Squire Patton Boggs (US) LLP
Jul
18
2024
HCS 2024 — A Conversation with Karin F. Baron [Podcast] Bergeson & Campbell, P.C.
Jul
18
2024
Massachusetts Superior Court Holds That New HCA Law Does Not Apply Retroactively Blank Rome LLP
Jul
18
2024
Federal Circuit Provides Insight on Induced Infringement Claims in Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. Sheppard, Mullin, Richter & Hampton LLP
Jul
18
2024
FDA Study Confirms Pasteurization Kills Bird Flu Virus in Milk Keller and Heckman LLP
Jul
18
2024
Telehealth: Regulatory Questions Amid Legislative Uncertainty McDermott Will & Emery
Jul
18
2024
Double Trouble: When D&O Insurance Fails Executives in Dual-Capacity Roles Hunton Andrews Kurth
Jul
18
2024
Because I Got High: Settlement Reached in Terminated Hemp User’s Disability Bias Suit Bradley Arant Boult Cummings LLP
Jul
18
2024
What U.S. Supreme Court Decision on Standing Tells Us About Challenges to Corporate DEI Initiatives Jackson Lewis P.C.
Jul
17
2024
The FTC’s Challenge to the Listing of Device Patents in the Orange Book: What Challenge? Polsinelli PC
Jul
17
2024
2024 Spring Regulatory Agenda Released – Suggests Rulemaking Regarding N-acetyl-L-cysteine Keller and Heckman LLP
Jul
17
2024
Preliminary Injunction Halts Sales of Tumor-Informed Cancer Screening Test Bradley Arant Boult Cummings LLP
Jul
17
2024
The 2025 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know ArentFox Schiff LLP
Jul
16
2024
Supreme Court Decision Overturns Chevron: Impact on Cannabis Industry Norris McLaughlin P.A.
Jul
16
2024
June 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Jul
16
2024
Navigating the Legal Boundaries of Telehealth Womble Bond Dickinson (US) LLP
Jul
16
2024
The Science of Drug Testing Womble Bond Dickinson (US) LLP
Jul
16
2024
Defense Contracting, Cybersecurity and COVID: Major Qui Tam Settlements from June 2024 Kohn, Kohn & Colapinto
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins